KR
Keros Ther
KROS·NASDAQLexington MAFounded 2017100 employees
Small CapbiotechPublicHematologyCardiology
Platform: TGF-β trap
Market Cap
$1.5B
All Drugs
2
Clinical Trials
3
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (KROS)
Loading KROS stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| KRO-9986 | KRO-9986 | Phase 3 | 2 | TIGIT | RSVCKD | ||
| Voxacapivasertib | KRO-9623 | Phase 1/2 | 1 | BET | MS |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (2)